BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9646607)

  • 41. Identification of an electron densification of the glomerular basement membrane in renal biopsy specimens.
    Sato S; Ishizaki M; Shimizu A; Ghazizadeh M; Kitamura H; Adachi A; Sasaki Y; Dai W; Wakamatsu K; Sugisaki Y
    Med Electron Microsc; 2003 Jun; 36(2):106-11. PubMed ID: 12825124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Terminal complement complex (TCC) levels in urine in patients with renal diseases].
    Yasuda K
    Hokkaido Igaku Zasshi; 2001 Mar; 76(2):71-84. PubMed ID: 11344904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells?
    Smeets B; Dijkman HB; Wetzels JF; Steenbergen EJ
    J Pathol; 2006 Nov; 210(3):263-72. PubMed ID: 16924588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Histological classification of chronic glomerular diseases].
    Noël LH; Gubler MC
    Rev Prat; 2003 Nov; 53(18):2005-12. PubMed ID: 15008214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy.
    Pontrelli P; Rossini M; Infante B; Stallone G; Schena A; Loverre A; Ursi M; Verrienti R; Maiorano A; Zaza G; Ranieri E; Gesualdo L; Ditonno P; Bettocchi C; Schena FP; Grandaliano G
    Transplantation; 2008 Jan; 85(1):125-34. PubMed ID: 18192922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New rat model induced by anti-glomerular basement membrane antibody shows severe glomerular adhesion in early stage and quickly progresses to end-stage renal failure.
    Nakano Y; Hirano T; Uehara K; Nishibayashi S; Hattori K; Aihara M; Yamada Y
    Pathol Int; 2008 Jun; 58(6):361-70. PubMed ID: 18477215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Methods of eliminating immune complexes in kidney disease patients (a review of the literature)].
    Taran EI
    Vrach Delo; 1984 Aug; (8):61-6. PubMed ID: 6239451
    [No Abstract]   [Full Text] [Related]  

  • 48. [Some aspects of cellular and humoral immunity in glomerulonephritis].
    Dall'Aglio P; Meroni PL; Balestrieri G; Allegri L; Calderini C; Ciccone E; De Bartolo G; Messina C; Tincani A
    Minerva Nefrol; 1981; 28(3):393-402. PubMed ID: 7329617
    [No Abstract]   [Full Text] [Related]  

  • 49. [Circulating immune complexes in kidney diseases: pathogenic significance, methods of proof, problems, tendencies].
    Behm E
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 41-3. PubMed ID: 6451092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histopathological atlas of renal diseases: Minimal Change disease and focal glomerulosclerosis.
    Ferrario F; Rastaldi MP
    J Nephrol; 2005; 18(1):1-4. PubMed ID: 15772916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Serum laminin concentration in renal diseases].
    Horikoshi S; Funabiki K; Abe S; Koide H
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):745-8. PubMed ID: 3172570
    [No Abstract]   [Full Text] [Related]  

  • 52. [Application of immunological tests of the serum and urine--detection of the serum antigens and antibodies and fluorescent antibody technic for the renal tissue].
    Nagasawa T
    Rinsho Byori; 1982 Mar; Suppl 49():81-7. PubMed ID: 7050465
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunologic aspects of renal disease.
    Ambrus JL; Sridhar NR
    JAMA; 1997 Dec; 278(22):1938-45. PubMed ID: 9396656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of immune complexes in pathogenesis of renal disease.
    Nydegger UE; Wegmüller E
    Immunol Lett; 1987 Feb; 14(3):229-34. PubMed ID: 2437019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.
    DIXON FJ; FELDMAN JD; VAZQUEZ JJ
    J Exp Med; 1961 May; 113(5):899-920. PubMed ID: 13723140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical aspects and therapy of the kidney diseases. Pathological report].
    Chiari H
    Wien Klin Wochenschr; 1967 Sep; 79(35):637-42. PubMed ID: 5593717
    [No Abstract]   [Full Text] [Related]  

  • 57. Tissue factor in crescentic glomerulonephritis.
    McCluskey RT
    Am J Pathol; 1997 Mar; 150(3):787-92. PubMed ID: 9060816
    [No Abstract]   [Full Text] [Related]  

  • 58. [Specific lymphocyte sensitization in nephropathies].
    Savitskiĭ SN; Gordovskaia NB; Shilov EM; Pan'shin AG; Traianova TG
    Urol Nefrol (Mosk); 1980; (3):18-23. PubMed ID: 7385470
    [No Abstract]   [Full Text] [Related]  

  • 59. Intrarenal insoluble immune complex formation.
    Clark WF; Turnbull DI; Driedger AA; Lindsay RM; Linton AL
    J Clin Lab Immunol; 1980 Jul; 4(1):21-5. PubMed ID: 7463472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Significance of the immunological factor in the pathogenesis of kidney diseases].
    Dimitriu CG; Zeană C
    Med Interna (Bucur); 1971 Aug; 23(8):959-67. PubMed ID: 5093854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.